Search results for " mellitus"

showing 10 items of 2078 documents

Crataegus laevigata decreases neutrophil elastase and has hypolipidemic effect: a randomized, double-blind, placebo-controlled trial.

2011

Crataegus laevigata is a medicinal plant most commonly used for the treatment of heart failure and psychosomatic disorders. Based on previous experimental findings, this double-blind placebo-controlled study was aimed at finding beneficial effects of C. laevigata on biomarkers of coronary heart disease (CHD). The study included 49 diabetic subjects with chronic CHD who were randomly assigned to the treatment for 6 months with either a micronized flower and leaf preparation of C. laevigata (400 mg three times a day) or a matching placebo. Blood cell count, lipid profile, C-reactive protein, neutrophil elastase (NE) and malondialdehyde were analyzed in plasma at baseline, at one month and six…

medicine.medical_specialtyPlacebo-controlled studyPharmaceutical ScienceCoronary DiseaseFlowersPlaceboGastroenterologyDiabetes Complicationschemistry.chemical_compoundDouble-Blind MethodInterquartile rangeInternal medicineDiabetes mellitusDrug DiscoverymedicineHumansAgedPharmacologyCrataegusmedicine.diagnostic_testbiologybusiness.industryCholesterolPlant ExtractsC-reactive proteinCholesterol LDLMiddle Agedbiology.organism_classificationmedicine.diseaseSurgeryCrataegus laevigataPlant LeavesC-Reactive ProteinComplementary and alternative medicinechemistryDiabetes Mellitus Type 2biology.proteinMolecular MedicineLipid PeroxidationLipid profilebusinessLeukocyte ElastasePhytotherapyPhytomedicine : international journal of phytotherapy and phytopharmacology
researchProduct

Experiences of a poison center with metformin-associated lactic acidosis.

2004

Metformin is widely used in the treatment of type 2 diabetes, though it is recognized to be associated with the risk of lactic acidosis. A case of pronounced lactic acidosis with cardiac arrest (pH 6.60, lactate 17.5 mmol/l, base excess - 30, standard bicarbonate 2.5 mmol/l, core body temperature 27.8 degrees C) is presented in a 61-year-old woman under metformin therapy. The key laboratory abnormalities observed during the intensive care treatment including repeated hemodialysis are described. The patient showed a complete recovery with residually reduced mental capabilities. Furthermore, an explorative data analysis of our poison center database from 1995 until 2003 concerning metformin w…

medicine.medical_specialtyPoison Control Centersendocrine system diseasesEndocrinology Diabetes and MetabolismPoison controlSuicide AttemptedType 2 diabetesGastroenterologyEndocrinologyInternal medicineInternal MedicinemedicineHumansHypoglycemic AgentsAcidosisbusiness.industryMetabolic disordernutritional and metabolic diseasesMetabolic acidosisGeneral MedicineMiddle Agedmedicine.diseaseMetforminSurgeryMetforminDiabetes Mellitus Type 2Lactic acidosisBase excessAcidosis LacticFemalemedicine.symptombusinessmedicine.drugExperimental and clinical endocrinologydiabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
researchProduct

Coronavirus disease 2019 in chronic kidney disease

2020

Abstract The clinical spectrum of coronavirus disease 2019 (COVID-19) infection ranges from asymptomatic infection to severe pneumonia with respiratory failure and even death. More severe cases with higher mortality have been reported in older patients and in those with chronic illness such as hypertension, diabetes or cardiovascular diseases. In this regard, patients with chronic kidney disease (CKD) have a higher rate of all-type infections and cardiovascular disease than the general population. A markedly altered immune system and immunosuppressed state may predispose CKD patients to infectious complications. Likewise, they have a state of chronic systemic inflammation that may increase …

medicine.medical_specialtyPopulation030232 urology & nephrologyDiseaseurologic and male genital diseasesSystemic inflammationAsymptomaticlaw.invention03 medical and health sciences0302 clinical medicinecardiovascular diseaselawChronic kidney diseaseInternal medicineDiabetes mellitusmedicineeducationCKJ ReviewstherapyTransplantationeducation.field_of_studySARS-CoV-2business.industryImmunityCOVID-19Cardiovascular diseasemedicine.diseaseimmunityIntensive care unitVirusPneumoniaNephrologyTherapymedicine.symptombusinesschronic kidney diseaseKidney diseaseClinical Kidney Journal
researchProduct

Diabetes Mellitus and Its Association to the Occurrence of Medication-Related Osteonecrosis of the Jaw

2016

To date there is no consensus on the role of diabetes in the development of medication-related osteonecrosis of the jaws (MR-ONJ). Therefore, this study aimed to investigate the prevalence of diabetes and pathological glucose metabolism in patients with MR-ONJ compared to the general population. All maxillofacial surgery inpatients in one year at our department were investigated regarding diagnosis, anamnesis, medication, and blood glucose readings. 1374 records were analyzed. 35 patients with MR-ONJ were identified. Diabetics accounted for 14.3%. No significant difference in the prevalence of known diabetes was found, except for pathological glucose metabolism in patients with MR-ONJ (p &l…

medicine.medical_specialtyPopulationArticle03 medical and health sciences0302 clinical medicineInternal medicineDiabetes mellitusmedicinediabetes; hyperglycemia; bisphosphonates; denosumab; MR-ONJ; BP-ONJRisk factoreducationGeneral DentistryPathologicalbisphosphonatesAnamnesiseducation.field_of_studyBP-ONJdiabetesbusiness.industrySignificant differencedenosumab030206 dentistrymedicine.diseaseSurgerylcsh:RK1-715Denosumab030220 oncology & carcinogenesislcsh:DentistryMR-ONJhyperglycemiaOsteonecrosis of the jawbusinessmedicine.drugDentistry Journal; Volume 4; Issue 2; Pages: 17
researchProduct

Multimodal surgical and medical treatment for extensive rhinocerebral mucormycosis in an elderly diabetic patient: a case report and literature review

2014

Diabetes is a well-known risk factor for invasive mucormycosis with rhinocerebral involvement. Acute necrosis of the maxilla is seldom seen and extensive facial bone involvement is rare in patients with rhino-orbital-cerebral mucormycosis. An aggressive surgical approach combined with antifungal therapy is usually necessary. In this report, we describe the successful, personalized medical and surgical management of extensive periorbital mucormycosis in an elderly diabetic, HIV-negative woman. Mono- or combination therapy with liposomal amphotericin B (L-AmB) and posaconazole (PSO) and withheld debridement is discussed. The role of aesthetic plastic surgery to preserve the patient’s physical…

medicine.medical_specialtyPosaconazoleDebridementFacial boneCombination therapySettore MED/17 - Malattie Infettivebusiness.industrymedicine.medical_treatmentMucormycosislcsh:RSettore MED/19 - Chirurgia Plasticalcsh:MedicineCase ReportGeneral MedicineSettore MED/08 - Anatomia Patologicamedicine.diseaseSurgerySettore MED/13 - EndocrinologiaPlastic surgeryDiabetes mellitusMedicineRhinocerebral Mucormycosis DiabetesRisk factorbusinessmedicine.drug
researchProduct

The proprioceptive insole: A therapeutic aid for the diabetic patient in prevention?

2021

The diabetic foot represents one of the most common complications among patients with type 2 diabetes mellitus. Prevention of the diabetic foot is therefore essential both to ensure the patient a better quality of life and to reduce the costs borne by the NHS and this requires a multidisciplinary approach. It is important to underline that the major complications of the diabetic foot are due to biomechanical, vascular and neuropathic alterations. Diabetic patients are less likely to perform physical exercises and tend to walk less, adopting compensatory strategies based on the type of terrain they find. They walk slower, tend to take shorter steps with a wider base of support, have limited …

medicine.medical_specialtyPosturologyProprioceptionbusiness.industryDiabetesBiomechanicsType 2 Diabetes Mellitusmedicine.diseaseProprioceptionDiabetic footInsoleDiabetic footPhysical medicine and rehabilitationmedicine.anatomical_structureQuality of lifeDiabetes mellitusPostural BalanceEducación Física y DeportivaMedicineBiomechanicsAnklebusiness
researchProduct

Synthesis and in vitro evaluation of (S)-2-([11C]methoxy)-4-[3-methyl-1-(2-piperidine-1-yl-phenyl)-butyl-carbamoyl]-benzoic acid ([11C]methoxy-repagl…

2004

The 11 C-labeled sulfonylurea receptor 1 (SUR1) ligand (S)-2-(( 11 C)methoxy)-4-(3-methyl-1-(2-piperidine-1-yl-phenyl)- butyl-carbamoyl)-benzoic acid (( 11 C)methoxy-repaglinide) was synthesized in an overall radiochemical yield of 35% after 55 min with a radiochemical purity higher than 99%. This compound is considered for the noninvasive investigation of the SUR1 receptor status of pancreatic b-cells by positron emission tomography (PET) in the context of type 1 and type 2 diabetes. The specific activity was 40-70 GBq/lmol. In vitro testing of the nonradioactive methoxy-repaglinide was performed to characterize the affinity for binding to the human SUR1 isoform. Methoxy-repaglinide induce…

medicine.medical_specialtyPotassium Channelsmedicine.medical_treatmentReceptors DrugClinical BiochemistryPharmaceutical ScienceType 2 diabetesIn Vitro TechniquesSulfonylurea ReceptorsBiochemistryBenzoatesBinding CompetitiveIslets of LangerhansPiperidinesDiabetes mellitusInternal medicineDrug DiscoveryInsulin SecretionmedicineAnimalsHumansInsulinCarbon RadioisotopesPotassium Channels Inwardly RectifyingMolecular BiologyIC50Type 1 diabetesChemistryInsulinOrganic ChemistryStereoisomerismmedicine.diseaseRepaglinideLigand (biochemistry)RatsEndocrinologyPositron-Emission TomographyCOS CellsMolecular MedicineSulfonylurea receptorATP-Binding Cassette TransportersCarbamatesRadiopharmaceuticalsHydroxybenzoate Ethersmedicine.drugBioorganicmedicinal chemistry letters
researchProduct

Effects of prandial glycemic changes on objective fetal heart rate parameters

2000

Background. There is confusion in the literature about the potential effect of maternal glucose levels on the fetal heart rate (FHR) cardiotocographic interpretation.Methods. Study design: prospective clinical descriptive study. Subjects: 21 pregnant women with diabetes mellitus, 23 women with gestational diabetes and 18 healthy non-diabetic pregnant volunteers (control group). Treatment: maternal capillary glucose measurement and objective FHR analysis (Oxford System 8002) pre- and 1 h post-meal. Statistical analysis: descriptive statistics, Student t-tests and Pearson correlation studies.Results. Maternal capillary glucose levels ranged between 2.7–10.5 mmol/l pre-meal and 4.2–14.8 mmol/l…

medicine.medical_specialtyPregnancymedicine.diagnostic_testbusiness.industryObstetricsdigestive oral and skin physiologyGlucose MeasurementObstetrics and GynecologyGeneral Medicinemedicine.diseaseGestational diabetesPostprandialEndocrinologyInternal medicineDiabetes mellitusembryonic structuresHeart ratemedicineCardiotocographybusinessGlycemicActa Obstetricia et Gynecologica Scandinavica
researchProduct

Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with an…

2020

Digital

medicine.medical_specialtyProportional hazards modelbusiness.industryHazard ratioType 2 diabetes030204 cardiovascular system & hematologyCardiovascular diseasemedicine.diseasePlaceboMetforminMetformin03 medical and health sciences0302 clinical medicineDiabetes mellitusInternal medicineGLP-1-based therapymedicineDulaglutide030212 general & internal medicinePrediabetesMortalityMorbidityCardiology and Cardiovascular Medicinebusinessmedicine.drugEuropean Heart Journal
researchProduct

Diabetic Kidney Disease

2010

Diabetic nephropathy (DN) is the leading cause of chronic kidney disease and end-stage renal disease (ESRD). Patients with diabetic nephropathy have a high burden of cardiovascular morbidity and mortality. Therefore, interventions that reduce the incidence and progression rate of DN will reduce morbidity and mortality rates as well as health care costs. Hyperglycemia and arterial hypertension are the two main risk factors for DN, but even in the presence of hyperglycemia and elevated blood pressure (BP) for long periods, DN develops only in susceptible patients. Family studies have confirmed the presence of hereditary factors in the development of DN. Besides these four key factors, others …

medicine.medical_specialtyProteinuriabusiness.industryMortality rateIncidence (epidemiology)Diseasemedicine.diseaseNephropathyDiabetic nephropathyDiabetes mellitusInternal medicineMedicinemedicine.symptombusinessIntensive care medicineKidney disease
researchProduct